Skip to main content

Table 1 Factor Analysis [12] of Mania and Depression Symptoms

From: Symptoms predicting remission after divalproex augmentation with olanzapine in partially nonresponsive patients experiencing mixed bipolar I episode: a post-hoc analysis of a randomized controlled study

Factor No. Name

Scale Items

Mean Contribution To HDRS-21 + YMRS Total Score

Eigenvalue

Pearson Correlation Coefficient with CGI

(p value)

1. Sleep disturbance

YMRS 4 Sleep HDRS-21 4 Early Insomnia HDRS-21 5 Middle Insomnia HDRS-21 6 Late Insomnia

13.90%

2.82

0.073 (0.301)

2. Psychomotor activity

YMRS 1 Elevated Mood YMRS 2 Increased Psychomotor Activity YMRS 6 Rapid Speech HDRS-21 9 Agitation

19.70%

2.53

0.253 (< .001)*

3. Insight

YMRS 11 Lack of Insight HDRS 17 Lack of Insight

0.40%

2.26

-0.043 (0.541)

4. Work impairment/Somatization

HDRS-21 7 Work and Activities HDRS-21 11 Somatic Anxiety HDRS-21 13 General Somatic Symptoms

12.80%

2.10

0.293 (< .001)*

5. Irritability

YMRS 5 Irritability YMRS 9 Disruptive Aggressive Behavior HDRS-21 1 Depressed Mood

20.70%

1.83

0.181 (< .01)*

6. Variation/Derealization/Obsession

HDRS-21 18b Diurnal Variation HDRS-21 19 Depersonalization and Derealization HDRS-21 21 Obsessional and Compulsive Symptoms

2.90%

1.70

0.073 (0.303)

7. Sexuality

YMRS 3 Sexual Interest HDRS-21 14 Genital Symptoms (reverse)

3.80%

1.48

-0.120 (0.089)

8. Guilt/Suicidality

HDRS-21 2 Feelings of Guilt HDRS-21 3 Suicide

4.80%

1.38

0.256 (< .001)*

9. Appearance/GI

YMRS 10 Appearance HDRS-21 12 Somatic Symptoms (gastrointestinal) HDRS-21 16 Loss of Weight

3.10%

1.28

0.298 (< .001)*

10. Thought disorder

YMRS 8 Content HDRS-21 20 Paranoid Symptoms

6.40%

1.25

0.012 (0.871)

11. Retardation/Hypochondriasis

HDRS-21 8 Psychomotor Retardation (reverse) HDRS-21 15 Hypochondriasis

9.90%

1.08

0.118 (0.094)

  1. * Statistically-significant (p < .05). GI: Gastrointestinal